European Reference Networks

European Reference Networks (ERNs) are virtual networks involving healthcare providers across Europe. They aim to facilitate discussion on complex or rare diseases and conditions that require highly specialised treatment, and concentrated knowledge and resources.  This system facilitates equality of care for patients with complex or rare diseases within the European Union.


The ERN initiative receives support from several EU funding programmes, including the Health Programme, the Connecting Europe Facility and Horizon

Frequently Asked Questions

Who benefits from ERNs?
  • Patients with complex or rare diseases
  • Clinicians and Healthcare Professionals
  • Researchers in the field of complex and rare diseases
  • Countries where there is no specialisation in the field of the specific complex and rare disease
How does it work?
How can I be referred?

Locally a patient with a Rare Diseases/condition needs to be referred for discussion with the ERNs by the Consultant through a standard procedure similar to the Treatment Abroad referral procedure

What is the role of Mater Dei Hospital in the ERNs?

MDH is the National coordinating hub for all the current 24 European Reference Networks and is an Affiliated Partner in all the ERNs.  A National Coordinator for ERNs who is part of the Treatment Abroad Section within MDH is the focal point for all ERN and CPMS based activities.  Carol Fenech can be reached on 25457158 or on email: carol.fenech.1@gov.mt for further information.

What is the CPMS?

The Clinical Patient Management System is an online tool developed by the EU so that networking among the different Clinicians is possible through the ERNs

Is patient data safe when uploaded online?

The CPMS is a safe environment where patient information can be shared in a secure and protected manner.  Patient personal information is not uploaded and the data provided online is of the rare disease.  All data is therefore anonymised and there is no risk of data protection infringement.  The patient may also give consent to be contacted for research purposes and to be listed in the Rare Disease register.  No data is processed without prior patient’s consent

Facts about ERNs

0
Highly-specialised healthcare units
0
Hospitals
0
EU Countries

The first ERNs were launched in March 2017, involving more than 900 highly-specialised healthcare units from over 300 hospitals in 26 EU countries.  These will double in the coming year because a new membership drive has been launched because of the success of the networks.  24 ERNs are working on a range of thematic issues including bone disorders, childhood cancer and immunodeficiency. All ERNs have a website with all the required information per network including the rare diseases covered and the Members and affiliated partners involved.

List of European Reference Networks

  • ERN BOND

    Bones

  • ERN CRANIO

    Craniofacial anomalies and ear, nose and throat (ENT)

  • ENDO-ERN

    Endocrine conditions

  • EpiCARE

    Epilepsies

  • ERKNET

    Kidneys

  • ERNRND

    Neurological Diseases

  • ERNICA

    Inherited and congenital anomalies

  • ERN LUNG

    Respiratory Diseases

  • ERN-Skin

    Skin Disorders

  • EURACAN

    Rare adult cancers (solid tumours)

  • ERN-EuroBloodNet

    Haematological diseases

  • EURO-NMD

    Neuromuscular

Clinical Focal Points

Each ERN has its local Clinical focal points all based at MDH. 

Please contact Carol Fenech, National Coordinator for ERNS at MDH for further information on 25457158 or email her on carol.fenech.1@gov.mt

 

Legislation

  • Directive 2011/24/EU  on patients’ rights in cross-border healthcare
  • Commission delegated decision (annex) defining the criteria and conditions that healthcare providers and the ERNs should fulfil
  • Commission implementing decision (annex) defining criteria for establishing and evaluating ERNs
  • Commission Implementing Decision (EU) 2019/1269 of 26 July 2019 amending Implementing Decision 2014/287/EU

Coordination

The ERN initiative is mainly driven by EU countries. The Board of Member States is the formal body in charge of the approval and termination of networks and memberships as provided in the Commission’s Implementing Decision. The Board is comprised of representatives of all EU countries and EEA countries.

Monitoring System

18 ERN indicators for the ERN monitoring system were adopted by the Board of member States and presented at the 4th ERN Conference

This framework will help build a quality improvement system, define appropriate outcomes of the ERNs and identify areas of success and potential pitfalls and to demonstrate the added value of the ERNs.

Communication Materials

Learning Opportunities and Networking

The ERNs also provide and promote learning through webinars, courses and exchange programmes  to clinicians and healthcare professionals in tertiary centres who are also members of the ERNs, as well as collaborations and networking initiatives amongst healthcare professionals on the ERNs respective rare disease group.

 

Information on this page was last updated on: